Wczytywanie spółki
Just reported
Q3 2026 results
From Privia Health's results release of 5 listopada 2026; its quarterly report has since been filed.
Revenue
Actual
657M USD
+13% y/y
+3,8% q/qGuided
—
No guide given
EPS, GAAP
Actual
0,10 USD
+100% y/y
+43% q/qGuided
—
No guide given
Operating income, GAAP
Actual
20,5M USD
+43% y/y
+74% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Privia Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Health Information Services
Graded A or B and worth $2B or more: A first, then the largest.
VEEVVeeva Systems Inc.49B USDA+
BTSGBrightSpring Health Services, Inc.14,2B USDA
HNGEHinge Health, Inc.9,8B USDA+
HQYHealthequity, Inc.8,5B USDA+
DOCSDoximity, Inc.5,9B USDB+
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
BIIBBiogen Inc.28 paź 2026BAGraded B, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki Privia Health Group, Inc. składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
